On the other hand, the PD-1 pathway and CD28-mediated co-stimulatory pathway were negatively enriched in the low AUC group at T3, indicating a dysregulated T cell activation in the severe COVID-19 patients (32). This evidence concerns the gene CD28 and COVID-19.